Culturally-Tailored Internet-Based Smoking Cessation Program in Quitting Smoking in Tribal College Students

Inclusion Criteria

• Currently enrolled at Salish Kootenai College
• Have a valid telephone number and email address
• Willing to participate in all study components
• Willing to be followed-up for 6 months
• Self identifies as American Indian or Alaska native
• Is a current smoker – self defined

Exclusion Criteria

• Planning to leave the college within next 6 months
• Medically ineligible as a result of screening questions
• For nicotine replacement therapy (NRT) (patch, gum, lozenge): * History of severe eczema or any serious skin problem if requested nicotine patch * History of severe allergic reaction to the nicotine patch or other skin adhesives * History of heart attack in the last 2 months * Currently experiencing frequent angina or chest pain related to heart * Currently experiencing signs and symptoms of peptic ulcer * Currently receiving medications for rapid or irregular heart beat * Currently experiencing signs and symptoms of severe, uncontrolled high blood pressure
• For Chantix: * Pregnant or breast feeding or planning to become pregnant in the next 6 months * Currently using nicotine replacement therapy (NRT) * History of suicide attempt in the past 12 months * History of thoughts of suicide in the past 12 months * History of thoughts of harming others in the past 12 months
• For Zyban: * Pregnant or breast feeding or planning to become pregnant in the next 6 months * History of seizure disorder or head trauma * History of severe allergic reaction to Zyban (also known as Wellbutrin, Bupropion) * History of eating disorder, such as anorexia or bulimia, which is overeating and throwing up * Currently taking Wellbutrin, Zyban or any other medications that contain bupropion * History of alcohol or substance abuse in the past year * Current excessive alcohol consumption defined as 14 or more alcoholic drinks per week and/or binge drinking (5 or more drinks on one occasion) 2 or more times in the past month * Use of monoamine oxidase (MAO) inhibitors, such as Nardil, tranylcypromine, phenelzine, or Parnate * Reported use of illegal drugs (opiates, cocaine, narcotics, or other stimulants such as diet pills) * Use of psychoactive medications, such as fluoxetine, doxepin, clonidine, or buspirone * Use of benzodiazepines, such as Xanax, Valium, Ativan, Klonopin in the past 2 weeks